Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background. In 1999, meningococcal serogroup C conjugate (MCC) vaccines were introduced in the United Kingdom for those under 19 years of age. The impact of this intervention on asymptomatic carriage of meningococci was investigated to establish whether serogroup replacement or protection by herd immunity occurred. Methods. Multicenter surveys of carriage were conducted during vaccine introduction and on 2 successive years, resulting in a total of 48,309 samples, from which 8599 meningococci were isolated and characterized by genotyping and phenotyping. Results. A reduction in serogroup C carriage (rate ratio, 0.19) was observed that lasted at least 2 years with no evidence of serogroup replacement. Vaccine efficacy against carriage was 75%, and vaccination had a disproportionate impact on the carriage of sequence type (ST)-11 complex serogroup C meningococci that (rate ratio, 0.06); these meningococci also exhibited high rates of capsule expression. Conclusions. The impact of vaccination with MCC vaccine on the prevalence of carriage of group C meningococci was consistent with herd immunity. The high impact on the carriage of ST-11 complex serogroup C could be attributed to high levels of capsule expression. High vaccine efficacy against disease in young children, who were not protected long-term by the schedule initially used, is attributed to the high vaccine efficacy against carriage in older age groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The reduction in carriage lasted for at least 2 years after vaccine introduction, with no evidence of serogroup replacement (199).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263
Multilocus Sequence Typing of Bacteria
Maiden, M. C. J. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.micro.59.030804.121325 · Cited by 915
Self-citationEffectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571 · cited 1×
“This was fortuitous given that the infant schedule used for MCC vaccines in the United Kingdom at the time of vaccine introduction did not confer long term protection [27].”
BackgroundSelf-citationSequence type analysis and recombinational tests (START)
Jolley, K. A., Feil, E. J., Chan, M.-S., & Maiden, M. C. J. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.12.1230 · Cited by 512
Self-citationmlstdbNet – distributed multi-locus sequence typing (MLST) databases
Jolley, K. A., Chan, M.-S., & Maiden, M. C. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-86 · Cited by 501
Self-citationMiller, E., Salisbury, D., & Ramsay, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 482
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., & Lowenthal, J. P. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.5.514 · Cited by 446
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica
Cartwright, K. A. V., Stuart, J. M., Jones, D. M., & Noah, N. D. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066449 · Cited by 421
Self-citationMaiden, M. C., & Stuart, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08679-8 · Cited by 418 · cited 4×
“bacteria [13], which, although rarely isolated from carriers, are”
BackgroundInfluentialSelf-citationHerd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., & Miller, E. (2003) · BMJ · doi:10.1136/bmj.326.7385.365 · Cited by 411
Self-citationDagan, R., Givon‐Lavi, N., Zamir, O., Sikuler‐Cohen, M., Guy, L., Janco, J., Yagupsky, P., & Fraser, D. (2002) · The Journal of Infectious Diseases · doi:10.1086/339525 · Cited by 339
Borrow, R., Andrews, N., Goldblatt, D., & Miller, E. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1568-1573.2001 · Cited by 316
Self-citationAsymptomatic carriage of Neisseria meningitidis in a randomly sampled population
Caugant, D. A., Høiby, E. A., Magnus, P., Scheel, O., Hoel, T., Bjune, G., Wedege, E., Eng, J., & Frøholm, L. O. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.323-330.1994 · Cited by 312
Population genetics and molecular epidemiology of Neisseria meningitidis
CAUGANT, D. A. (1998) · APMIS · doi:10.1111/j.1699-0463.1998.tb01379.x · Cited by 255
Yazdankhah, S. P., Kriz, P., Tzanakaki, G., Kremastinou, J., Kalmusova, J., Musilek, M., Alvestad, T., Jolley, K. A., Wilson, D. J., McCarthy, N. D., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5146-5153.2004 · Cited by 244
Self-citationSocial Behavior and Meningococcal Carriage in British Teenagers
MacLennan, J., Kafatos, G., Neal, K., Andrews, N., Cameron, J. C., Roberts, R., Evans, M. R., Cann, K., Baxter, D. N., Maiden, M. C. J., et al. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1206.051297 · Cited by 240
Self-citationGray, S. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46288-0 · Cited by 221
Self-citationDAGAN, R., MUALLEM, M., MELAMED, R., LEROY, O., & YAGUPSKY, P. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199711000-00011 · Cited by 217
Haemophilus influenzae type b conjugate vaccines
Kelly, D. F., Moxon, E. R., & Pollard, A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01971.x · Cited by 214
Genetic Analysis of Meningococci Carried by Children and Young Adults
Claus, H., Maiden, M. C. J., Wilson, D. J., McCarthy, N. D., Jolley, K. A., Urwin, R., Hessler, F., Frosch, M., & Vogel, U. (2005) · The Journal of Infectious Diseases · doi:10.1086/428590 · Cited by 207
Self-citationClaus, H., Maiden, M. C. J., Maag, R., Frosch, M., & Vogel, U. (2002) · Microbiology · doi:10.1099/00221287-148-6-1813 · Cited by 176
Self-citationAntigenic and Epidemiologic Properties of the ET-37 Complex of Neisseria meningitidis
Wang, J. F., Caugant, D. A., Morelli, G., Koumaré, B., & Achtman, M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1320 · Cited by 164
Carried Meningococci in the Czech Republic: a Diverse Recombining Population
Jolley, K. A., Kalmusova, J., Feil, E. J., Gupta, S., Musilek, M., Kriz, P., & Maiden, M. C. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3549-3550.2002 · Cited by 163
Self-citationCohen, R., Levy, C., de La Rocque, F., Gelbert, N., Wollner, A., Fritzell, B., Bonnet, E., Tetelboum, R., & Varon, E. (2006) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000243163.85163.a8 · Cited by 158
Multilocus sequence typing for global surveillance of meningococcal disease
Brehony, C., Jolley, K. A., & Maiden, M. C. J. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00056.x · Cited by 154
Self-citationCarried Meningococci in the Czech Republic: a Diverse Recombining Population
Jolley, K. A., Kalmusová, J., Feil, E. J., Gupta, S., Musílek, M., Kriz, P., & Maiden, M. C. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.12.4492-4498.2000 · Cited by 151
Self-citationMeningococcal conjugate vaccines: new opportunities and new challenges
Maiden, M. C. J., & Spratt, B. G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00252-4 · Cited by 144
Self-citationHeath, P. T. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.6.396 · Cited by 138
BORROW, R., CLAUS, H., GUIVER, M., SMART, L., JONES, D. M., KACZMARSKI, E. B., FROSCH, M., & FOX, A. J. (1997) · Epidemiology and Infection · doi:10.1017/s0950268896007261 · Cited by 129
Self-citationAla’Aldeen, D. A. A., Neal, K. R., Ait‐Tahar, K., Nguyen‐Van‐Tam, J. S., English, A., Falla, T. J., Hawkey, P. M., & Slack, R. C. (2000) · Journal of Clinical Microbiology · doi:10.1128/.38.6.2311-2316.2000 · Cited by 104
Self-citationsiaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections
Borrow, R., Claus, H., Chaudhry, U., Guiver, M., Kaczmarski, E. B., Frosch, M., & Fox, A. J. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb12862.x · Cited by 68
Self-citationAlcalá, B., Arreaza, L., Salcedo, C., Uría, M. J., de la Fuente, L., & Vázquez, J. A. (2002) · Emerging infectious diseases · doi:10.3201/eid0812.020081 · Cited by 61
Stefanelli, P., Fazio, C., Neri, A., Sofia, T., & Mastrantonio, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5783-5786.2003 · Cited by 48
Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis
Pérez‐Trallero, E., Vicente, D. A., Montes, M., & Cisterna, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11061-0 · Cited by 46
Shigematsu, M., Davison, K. L., Charlett, A., & Crowcroft, N. S. (2002) · Epidemiology and Infection · doi:10.1017/s0950268802007549 · Cited by 31
The Impact of Meningococcal Serogroup C Conjugate Vaccine in Scotland
Mooney, J. D., Christie, P., Robertson, C., & Clarke, S. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421947 · Cited by 26
Self-citationDynamics of Bacterial Carriage and Disease: Lessons from the Meningococcus
Maiden, M. C. J. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8993-2_5 · Cited by 19
Self-citationJolley, K. A., Kalmusová, J., Feil, E. J., Gupta, S. K., Musílek, M., Kriz, P., & Maiden, M. C. J. (2002) · Journal of Clinical Microbiology · Cited by 19
Self-citationHaemophilus influenzae type b polysaccharide-protein conjugate vaccines in children
Eskola, J., Takala, A. K., & Käyhty, H. M. (1993) · Current Opinion in Pediatrics · doi:10.1097/00008480-199302000-00009 · Cited by 17
Improved Rate of Isolation of Neisseria meningitidis by Direct Plating of Pharyngeal Swabs
Cunningham, R., Matthews, R., Lewendon, G., Harrison, S., & Stuart, J. M. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.12.4575-4576.2001 · Cited by 15
Self-citation
Research works printed but not linked: 1
- 12. Jelfs J, Munro R, Ashton F, Rawlinson W, Caugant DA. Global study of variation in a new variant of the ET-37 complex of Neisseria meningitidis. In: Program and abstracts of the 11th International Pathogenic Neisseria Conference. Nice, France: Editions E.D.K., 1998 :5.
Cited by
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.007 · Cited by 919
Impact of Vaccines; Health, Economic and Social Perspectives
Rodrigues, C. M. C., & Plotkin, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01526 · Cited by 737
Meningococcal carriage by age: a systematic review and meta-analysis
Christensen, H., May, M., Bowen, L., Hickman, M., & Trotter, C. L. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70251-6 · Cited by 654
Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
Pollard, A. J., Perrett, K. P., & Beverley, P. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2494 · Cited by 485
Metadata
- Authors
- Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., Ala'Aldeen, D. A. A., Crook, D. W., Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E., MacLennan, J., Cameron, J. C., & Stuart, J. M.
- Affiliations
- John Radcliffe Hospital (GB)
- Health Protection Agency (GB)
- Health Protection Agency Centre for Infections, London
- University of Southampton (GB)
- Bangor University (GB)
- National Public Health Service for Wales, Unit 1, Parc Nantgarw, Cardiff
- Imperial College London (GB)
- University of Nottingham (GB)
- Division of Microbiology, School of Molecular Medical Sciences, Institute of Infection Immunity and Inflammation University of Nottingham
- South West Peninsula Health Protection Unit, Lescaze Offices, Dartington, Devon
- Derriford Hospital (GB)
- University of Manchester (GB)
- Manchester Royal Infirmary (GB)
- Health Protection Scotland (GB)
- Corresponding author
- Maiden, Martin C J
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-01
- Volume
- 197
- Issue
- 5
- Pages
- 737-743
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC6767871
- OpenAlex
- W2171028861
- Cited by
- 442
- References
- 41
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 9 · 2023: 16 · 2022: 10 · 2021: 21 · 2020: 18 · 2019: 21 · 2018: 29 · 2017: 32 · 2016: 24 · 2015: 40 · 2014: 22 · 2013: 28 · 2012: 45
- FWCI
- 35.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Wellcome Trust
- Scottish Executive Health Department
- Meningitis Trust
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- meningococcal serogroup C, conjugate vaccines, asymptomatic carriage, herd immunity, serogroup replacement, capsule expression, vaccine efficacy, young children, United Kingdom
- MeSH terms
- Adolescent, Adult, Carrier State, Cross-Sectional Studies, United Kingdom, Humans, Meningococcal Infections, Neisseria meningitidis, Serotyping, Meningococcal Vaccines, Immunity, Herd, Mass Vaccination, Neisseria meningitidis, Serogroup C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.